Tumor classification with MALDI-MSI data of tissue microarrays: A case study.

With mass spectrometry imaging (MSI) on tissue microarrays (TMAs) a large number of biomolecules can be studied for many patients at the same time, making it an attractive tool for biomarker discovery. Here we investigate whether lymph node metastasis can be predicted from MALDI-MSI data. Measurements are performed on TMAs and then filtered based on spectral intensity and the percentage of tumor cells, after which the resulting data for 122 patients is further preprocessed. We assume differences between patients with and without metastasis are expressed in a limited number of features. Two univariate feature selection methods are applied to reduce the dimensionality of the MALDI-MSI data. The selected features are then used in combination with three classifiers. The best classification scores are obtained with a decision tree classifier, which classifies about 72% of patients correctly. Almost all the predictive power comes from a single peak (m/z 718.4). The sensitivity of our classification approach, which can be generically used to search for biomarkers, is investigated using artificially modified data.

[1]  M. Clench,et al.  Novel molecular tumour classification using MALDI–mass spectrometry imaging of tissue micro-array , 2010, Analytical and bioanalytical chemistry.

[2]  E. Tajara,et al.  Proteomic Approaches Identify Members of Cofilin Pathway Involved in Oral Tumorigenesis , 2012, PloS one.

[3]  M. Kwiatkowski,et al.  MALDI imaging on large‐scale tissue microarrays identifies molecular features associated with tumour phenotype in oesophageal cancer , 2013, Histopathology.

[4]  R. Langer,et al.  How Suitable is Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight for Metabolite Imaging from Clinical Formalin-Fixed and Paraffin-Embedded Tissue Samples in Comparison to Matrix-Assisted Laser Desorption/Ionization-Fourier Transform Ion Cyclotron Resonance Mass Spectrometry? , 2016, Analytical chemistry.

[5]  Bill C. White,et al.  Proteomic patterns of tumour subsets in non-small-cell lung cancer , 2003, The Lancet.

[6]  M. Hilario,et al.  Processing and classification of protein mass spectra. , 2006, Mass spectrometry reviews.

[7]  Marius Ueffing,et al.  MALDI imaging mass spectrometry reveals COX7A2, TAGLN2 and S100-A10 as novel prognostic markers in Barrett's adenocarcinoma. , 2012, Journal of proteomics.

[8]  P ? ? ? ? ? ? ? % ? ? ? ? , 1991 .

[9]  P. V. van Diest,et al.  Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck. , 2013, The British journal of oral & maxillofacial surgery.

[10]  Richard M Caprioli,et al.  Protein signatures for survival and recurrence in metastatic melanoma. , 2011, Journal of proteomics.

[11]  Malte Buchholz,et al.  MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large‐scale tissue microarrays , 2013, International journal of cancer.

[12]  Thomas M. Harris,et al.  Proteomic analysis of oral cavity squamous cell carcinoma specimens identifies patient outcome-associated proteins. , 2015, Archives of pathology & laboratory medicine.

[13]  Marius Ueffing,et al.  Tissue‐based proteomics reveals FXYD3, S100A11 and GSTM3 as novel markers for regional lymph node metastasis in colon cancer , 2012, The Journal of pathology.

[14]  R. Casadonte,et al.  Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry , 2011, Nature Protocols.

[15]  Sameh Magdeldin,et al.  Toward deciphering proteomes of formalin-fixed paraffin-embedded (FFPE) tissues , 2012, Proteomics.

[16]  S. Rauser,et al.  S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging , 2011, Journal of Molecular Medicine.

[17]  Horst Zitzelsberger,et al.  Tumor classification of six common cancer types based on proteomic profiling by MALDI imaging. , 2012, Journal of proteome research.

[18]  R. Caprioli,et al.  Imaging the clear cell renal cell carcinoma proteome. , 2013, The Journal of urology.

[19]  I. Fournier,et al.  Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections. , 2007, Journal of proteome research.

[20]  J. Werner,et al.  Postoperative morbidity after different types of selective neck dissection , 2010, The Laryngoscope.

[21]  J. Rossier,et al.  Combination of peptide profiling by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and immunodetection on single glands or cells. , 1998, Analytical chemistry.

[22]  H. Schlüter,et al.  MALDI imaging mass spectrometry reveals multiple clinically relevant masses in colorectal cancer using large-scale tissue microarrays. , 2017, Journal of mass spectrometry : JMS.

[23]  Yu Shyr,et al.  Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. , 2005, Cancer research.

[24]  Ed Schuuring,et al.  Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[26]  S. Stoeckli,et al.  Advances in diagnostic modalities to detect occult lymph node metastases in head and neck squamous cell carcinoma , 2015, Head & neck.

[27]  Gert B. Eijkel,et al.  Correlating MALDI and SIMS imaging mass spectrometric datasets of biological tissue surfaces , 2009 .

[28]  S. Rauser,et al.  MALDI imaging identifies prognostic seven-protein signature of novel tissue markers in intestinal-type gastric cancer. , 2011, The American journal of pathology.

[29]  Peter Hoffmann,et al.  Citric acid antigen retrieval (CAAR) for tryptic peptide imaging directly on archived formalin-fixed paraffin-embedded tissue. , 2010, Journal of proteome research.